Results 191 to 200 of about 385,065 (234)

CAR-NK Engineering to Overcome TME Barriers. [PDF]

Cells
Islam F, Pupovac A, Boyd RL, Trounson AO.   +3 more
europepmc   +1 more source

Unlocking New Horizons: Antibody-Drug Conjugates in Small Cell Lung Cancer. [PDF]

Biology (Basel)
Liu J, Cui Y, Liao D, Sima M, Han M, Li W, Bi Y, Yue D.   +7 more
europepmc   +1 more source

Natural killer cell exhaustion in ovarian cancer: from molecular suppression to therapeutic revival. [PDF]

Front Immunol
Ning J, Yao L.
europepmc   +1 more source

Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]

Cancer Immunol Immunother
De Maria R, Donini C, Capellero S, Massa A, Galvagno F, Proment A, Vitali L, Vigna E, Landoni E, Dotti G, Leuci V, Accornero P, Cesar Conti L, Olimpo M, Berrino E, Grignani G, Sapino A, Sangiolo D, Aresu L.   +18 more
europepmc   +1 more source

Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies. [PDF]

Int J Mol Sci
Bria J, Filardo A, Di Vito A, Della Torre A, Lavano A, Coscarella I, Chiarella E, Procopio E, Egiziano MT, Longo P, La Torre D.   +10 more
europepmc   +1 more source

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer. [PDF]

J Exp Clin Cancer Res
Cattaneo G, Ventin M, Arya S, Bailey C, Vantaku VR, Jia J, Qi M, Maggs L, Wang X, Parangi S, Ferrone S, Ferrone CR.   +11 more
europepmc   +1 more source

Immune checkpoint biology in hepatocellular carcinoma (Review). [PDF]

Oncol Lett
Hsieh CH, Chuang PC.
europepmc   +1 more source

B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway. [PDF]

Front Oncol
Zhai A, Zou Q, Yin J, Ge S, Xiong X, Yan T, Xie X, Wang L.   +7 more
europepmc   +1 more source

Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma. [PDF]

Nat Commun
Song EZ, Timpanaro A, Meechan M, Elena-Sanchez L, Li LZ, Jamet S, Lau DS, Winter LI, Dun MD, Foster JB, Evans MK, Pattwell SS, Kalia V, Sarkar S, Jensen MC, Biery MC, Vitanza NA.   +16 more
europepmc   +1 more source

Computational structural optimization enhances IL13Rα2 - B7-H3 tandem CAR T cells to overcome antigen-heterogeneity-mediated tumor escape. [PDF]

Mol Ther
Meehl MM, Immadisetty K, Trivedi VD, Glowacki P, Prinzing B, Anido AA, Ibañez-Vega J, Leslie BJ, Babu MM, Krenciute G.   +9 more
europepmc   +1 more source